‘Conspiracy’: Kerala won't protect activists led by Trupti Desai to visit Sabarimala

News Network
November 26, 2019

Kochi, Nov 26: A team of gender rights activists led by Trupti Desai, which was headed for Sabarimala to offer prayers at Lord Ayyappa temple was denied police protection on Tuesday amidst protests by devotees, members of a right wing outfit and BJP here, against their entry into the shrine.

The Kerala government dubbed Desai's attempt to visit Sabarimala as a "conspiracy".

As soon as the team of activists landed at the airport here, they went to the city police commissionerate seeking protection to proceed to the hill shrine.

However, police declined to grant protection to them, citing the recent Supreme Court decision to review its 2018 order permitting women in all age groups into Sabarimala.

A large number of Ayyappa devotees, activists of the BJP and Sabarimala Karma Samiti gathered outside the commissionerate chanting 'Ayyappa Saranam' mantra protesting against Desai's visit.

Activist from Kerala, Bindu Ammini, who had joined Desai's team at the airport was attacked by the rightwing group member using pepper spray when she came out of the office of the commissioner to take some papers from their vehicle, police sources said.

Visuals aired by TV channels showed her being attacked.

The man identified as Srinath Padmanabhan has been arrested, police said.

Ammini, who was admitted to the general hospital here, has been discharged after the treatment, her lawyer said.

The agitators ended the protest following assurances from police officials that the women activists would not be given protection to visit the temple.

Ammini and Kanakadurga were the two women activists who had offered prayers at Sabarimala Lord Ayyappa temple under police security last year following the Supreme Court permitting entry of women in all age groups into the hill shrine.

Reacting cautiously, the CPI(M)-led LDF government condemned the attack on Ammini but made it clear that no women in the age group of 10 and 50 would be given police protection to climb the holy hills unless they get an order from the Supreme Court in this regard.

Kerala Devaswom Minister Kadakampally Surendran alleged conspiracy behind women's rights activist Trupti Desai's decision to visit Sabarimala.

"The government suspects a conspiracy behind Trupti Desai's decision to go to Sabarimala. She has come from Pune, a stronghold of the RSS and the BJP," the Minister told reporters in Thalassery.

Surendran alleged the move was to create trouble during a peaceful pilgrim season in Sabarimala.

Travancore Devaswom Board president N Vasu said the board was not informed about their plan to visit the temple.

Contending that the apex court has not stayed its 2018 order permitting women in the menstrual age group into the shrine, Ammini said theywould file a contempt of court petition in the top court against the state government for not providing them police security to visit the temple.

Congress leader Abhishek Manu Singhvi, who argued the Sabarimala case in the Supreme Court, said the likes of Desai can only do excesses in the name of activism while the final verdict for Sabarimala temple was still pending before the apex court.

"At least the sentiment of people associated with the temple must be respected before final verdict assigns rights," he said in a tweet.

Leader of Opposition in Kerala Assembly, Ramesh Chennithala, alleged "conspiracy" by the CPI(M) and the BJP to "sabotage" the ongoing pilgrimage to Sabarimala temple.

"While Desai is having Sangh Parivar connection, Ammini is a supporter of the CPI(M). Both of them have come to climb Sabarimala hills. This is a move to sabotage Sabarimala pilgrimage," he alleged.

The senior Congress leader also urged the government to take steps to maintain peace and sanctity of the temple.

Comments

abbu
 - 
Wednesday, 27 Nov 2019

RSS.. DEVOTEESS SHOULD OBEY THE SUPREME COURT VERDICT....... AND ALLOW WOMENS TO VISIT SABARIMALA TEMPLE........... SAME AS THEY ARE ADVISING MUSLIMS TO OBEY THE VERDICT OF BABRI MASJID....... FIRST YOU ACCEPT THE VERDICT OF SABARIMALA AND THEN MUSLIMS  WILL ALSO ACCEPT

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
July 19,2020

New Delhi, Jul 19: With the highest single-day spike of 38,902 cases reported in the last 24 hours, India's total COVID-19 tally on Sunday reached 10,77,618, informed the Union Health and Family Welfare Ministry on Sunday.

The death toll has gone up to 26,816 with 543 fatalities reported in the last 24 hours.

The Health Ministry said the total number of cases includes 3,73,379 active cases and 6,77,423 patients have been cured/discharged/migrated.

Maharashtra remains the worst affected state with 3,00,937 cases reported until Saturday.
Meanwhile, as per the information provided by the Indian Council of Medical Research (ICMR), 1,34,33,742 samples have been tested for COVID-19 till July 18, of these 3,61,024 samples were tested yesterday.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
January 7,2020

Mumbai, Jan 7: People protesting against the JNU violence were evicted from Gateway of India here on Tuesday morning as roads were getting blocked and tourists and common people were facing problems, a police official said.

Police had appealed to the protesters to shift but they didn't listen, so they were "relocated" to Azad Maidan, the official said.

Hundreds of people, including students, women and senior citizens - who assembled at the iconic Gateway of India since Sunday midnight - demanded action against the culprits and called for Union Home Minister Amit Shah's resignation.

Violence broke out in the Jawaharlal Nehru University (JNU) in Delhi on Sunday night as masked men armed with sticks and rods attacked students and teachers and damaged property on the campus.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 4,2020

Beijing/Zurich, Mar 4: China has approved the use of Swiss drugmaker Roche's anti-inflammation drug Actemra for patients who develop severe complications from the coronavirus as it urgently hunts for new ways to combat the deadly infection that is spreading worldwide.

China is hoping that some older drugs could stop severe cytokine release syndrome (CRS), or cytokine storms, an overreaction of the immune system which is considered a major factor behind catastrophic organ failure and death in some coronavirus patients.

Actemra, a biologic drug approved in 2010 in the United States for rheumatoid arthritis (RA), inhibits high Interleukin 6 (IL-6) protein levels that drive some inflammatory diseases.

China's National Health Commission said in treatment guidelines published online on Wednesday that Actemra can now be used to treat coronavirus patients with serious lung damage and high IL-6 levels.

Separately, researchers in the country are testing Actemra, known generically as tocilizumab, in a clinical trial expected to include 188 coronavirus patients and running until May 10.

Roche, which donated 14 million yuan ($2.02 million) worth of Actemra during February, said the trial was initiated independently by a third party with the aim of exploring the efficacy and safety of the drug in coronavirus patients with CRS.

It added that there was currently no published clinical trial data on the drug's safety or efficacy against the virus.

More than 3,000 people have died and 93,000 have been infected by the novel coronavirus thought to have originated in Wuhan, China, before spreading to around 90 countries including the United States, Italy, Switzerland, France and Germany.

The Swiss company, for which China is its No. 2 market behind the United States, also makes diagnostic gear to detect the coronavirus.

Since Actemra's approval a decade ago, it has become a go-to drug against other inflammatory conditions, including cytokine storms in cancer patients receiving cell therapies from Novartis and Gilead Sciences.

In 2012 it helped save the life of a young U.S. girl, the first child to be treated for leukaemia with Novatis' Kymriah, from a post-treatment rush of IL-6.

Priced at between $20-30,000 annually for RA according to SSR Health, Roche's medicine is also used for rare juvenile arthritis and giant cell arteritis, or inflammation of the blood vessels.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.